Moderna, Inc. (MRNA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Gilead Sciences, Inc.

Biogen, Inc.

Halozyme Therapeutics, Inc.

Bio-Techne Corp.

Amgen, Inc.

Elanco Animal Health, Inc.

Illumina, Inc.

BioMarin Pharmaceutical, Inc.

Moderna, Inc.

Vaxcyte, Inc.

Immunovant, Inc.

Why is Moderna, Inc. ?

NET SALES(Q) At USD 389 MM has Fallen at -19.96%
RAW MATERIAL COST(Y) Grown by 690.95% (YoY)
CASH AND EQV(HY) Lowest at USD 11,005 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 81.62%, its profits have risen by 20.8%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Moderna, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Moderna, Inc.

81.62%

-1.03

66.07%

S&P 500

24.32%

1.88

12.96%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.33%

EBIT Growth (5y)

-215.19%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.59

Sales to Capital Employed (avg)

0.38

Tax Ratio

1.44%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

82.29%

ROCE (avg)

68.02%

ROE (avg)

25.33%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.26

EV to EBIT

-4.69

EV to EBITDA

-5.04

EV to Capital Employed

4.14

EV to Sales

7.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-88.28%

ROE (Latest)

-32.62%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -1,466 MM

NET PROFIT(HY)

Higher at USD -2,169 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 14.36 times

DEBTORS TURNOVER RATIO(HY)

Highest at 9.82 times

-29What is not working for the Company

NET SALES(Q)

At USD 389 MM has Fallen at -19.96%

RAW MATERIAL COST(Y)

Grown by 690.95% (YoY

CASH AND EQV(HY)

Lowest at USD 11,005 MM

INTEREST(Q)

Highest at USD 17 MM

OPERATING PROFIT(Q)

Lowest at USD -1,329 MM

PRE-TAX PROFIT(Q)

Lowest at USD -1,334 MM

NET PROFIT(Q)

Lowest at USD -1,343 MM

EPS(Q)

Lowest at USD -3.4

Here's what is working for Moderna, Inc.

Operating Cash Flow

Highest at USD -1,466 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Highest at 14.36 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 9.82 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Moderna, Inc.

Net Sales

At USD 389 MM has Fallen at -19.96%

over average net sales of the previous four periods of USD 486 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -1,334 MM has Fallen at -92.77%

over average net sales of the previous four periods of USD -692 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -1,343 MM has Fallen at -90.36%

over average net sales of the previous four periods of USD -705.5 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Interest

At USD 17 MM has Grown at 112.5%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest

Highest at USD 17 MM

in the last five periods and Increased by 112.5% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit

Lowest at USD -1,329 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -1,334 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -1,343 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

EPS

Lowest at USD -3.4

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv

Lowest at USD 11,005 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost

Grown by 690.95% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales